Rebound Therapeutics Overview
- Year Founded
-
2015
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$102M
- Investors
-
1
Rebound Therapeutics General Information
Description
Developer of medical devices designed to offer medical devices for minimally invasive surgery (MIS) procedures. The company's medical devices include MIS access and therapeutic devices that offer state-of-the-art imaging and illumination technologies and are used for a variety of surgical procedures including neurosurgery, spine and orthopedic surgery, thoracic and general abdominal surgery, enabling physicians to carry out MIS procedures for the displacement of the large, complex and capital equipment in operating rooms
Contact Information
Website
www.reboundtx.comCorporate Office
- 13844 Alton Parkway
- Suite 120
- Irvine, CA 92618
- United States
Corporate Office
- 13844 Alton Parkway
- Suite 120
- Irvine, CA 92618
- United States
Rebound Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 09-Sep-2019 | $102M | Completed | Generating Revenue | ||
| 2. Early Stage VC (Series B) | 25-Jul-2017 | Completed | Stealth | |||
| 1. Seed Round | 29-Dec-2015 | $3.76M | $3.76M | Completed | Stealth |
Rebound Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Rebound Therapeutics Comparisons
Industry
Financing
Details
Rebound Therapeutics Competitors (2)
One of Rebound Therapeutics’s 2 competitors is NuVasive, a Formerly VC-backed company based in San Diego, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NuVasive | Formerly VC-backed | San Diego, CA | ||||
| Stryker | Formerly VC-backed | Portage, MI |
Rebound Therapeutics Patents
Rebound Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020336255-A1 | Cannula and obturator system | Inactive | 23-Aug-2019 | ||
| CA-3149499-A1 | Cannula and obturator system | Pending | 23-Aug-2019 | ||
| EP-4017385-A1 | Cannula and obturator system | Inactive | 23-Aug-2019 | ||
| EP-4017385-A4 | Cannula and obturator system | Inactive | 23-Aug-2019 | ||
| JP-2022544745-A | Cannula and obturator system | Pending | 23-Aug-2019 | A61B1/042 |
Rebound Therapeutics Former Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Invus Opportunities | Venture Capital | Minority | ||
| Wexford Capital | Asset Manager | Minority |
Rebound Therapeutics FAQs
-
When was Rebound Therapeutics founded?
Rebound Therapeutics was founded in 2015.
-
Where is Rebound Therapeutics headquartered?
Rebound Therapeutics is headquartered in Irvine, CA.
-
What industry is Rebound Therapeutics in?
Rebound Therapeutics’s primary industry is Surgical Devices.
-
Is Rebound Therapeutics a private or public company?
Rebound Therapeutics is a Private company.
-
What is the current valuation of Rebound Therapeutics?
The current valuation of Rebound Therapeutics is .
-
What is Rebound Therapeutics’s current revenue?
The current revenue for Rebound Therapeutics is .
-
How much funding has Rebound Therapeutics raised over time?
Rebound Therapeutics has raised $20.3M.
-
Who are Rebound Therapeutics’s investors?
Invus Opportunities and Wexford Capital have invested in Rebound Therapeutics.
-
Who are Rebound Therapeutics’s competitors?
NuVasive and Stryker are competitors of Rebound Therapeutics.
-
When was Rebound Therapeutics acquired?
Rebound Therapeutics was acquired on 09-Sep-2019.
-
Who acquired Rebound Therapeutics?
Rebound Therapeutics was acquired by Integra Lifesciences.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
